Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.0100 (-6.22%) ($29.9200 - $32.4400) on Thu. Sep. 6, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 54 | Latest Price | $30.0100(-6.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.445% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 0 () | Intraday Trend | -6.2% | | | |
|
Resistance Level | $30.73 | 5 Day Moving Average | $31.94(-6.04%) | 10 Day Moving Average | $31.45(-4.58%) | 20 Day Moving Average | $30.73(-2.34%) | To recent high | -26.8% | To recent low | 8.5% | Market Cap | $1.864b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |